{"id":"W4389869854","doi":"10.1002/jcph.2397","title":"Pharmacokinetics (PK) of Tiragolumab in First‐in‐Human Study in Patients with Mixed Solid Tumors (GO30103)","year":2023,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"F. Hoffmann-La Roche","keywords":"Atezolizumab; Pharmacokinetics; TIGIT; Dosing; Medicine; Pharmacology; Chemistry; Internal medicine; Cancer; Immunotherapy; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00672816,0.0001772,0.001186601,0.0006633154,0.00003220065,0.000004549081,0.0004787267,0.0001080507,0.001010521],"category_scores_gemma":[0.0003695506,0.0001159046,0.0001426635,0.001052828,0.0003328563,0.0000640802,0.0001590649,0.001859762,0.00001436254],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001195116,"about_ca_system_score_gemma":0.000269157,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006300134,"about_ca_topic_score_gemma":0.0002285151,"domain_scores_codex":[0.9948896,0.001397143,0.002292617,0.0001978756,0.0007485552,0.0004741688],"domain_scores_gemma":[0.9966574,0.001995025,0.0006408081,0.000227543,0.0002888119,0.0001903731],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01943447,0.006224545,0.9588514,0.00006408102,0.000285917,0.0007727169,0.001102726,0.001664581,0.005496539,0.000001102146,0.002983701,0.003118212],"study_design_scores_gemma":[0.0461553,0.008488831,0.9417619,0.0001233715,0.000174036,0.00001814965,0.000399118,0.00054483,0.001718057,0.00005002511,0.000464317,0.0001021266],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966361,0.00004984787,0.000001107733,0.001379282,0.0006035367,0.00104999,0.000002959351,0.000008589649,0.0002685822],"genre_scores_gemma":[0.9986606,0.0003013987,0.00001399872,0.0003427552,0.0003503265,0.000009975717,0.00000231294,0.00003467745,0.0002839747],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02672083,"threshold_uncertainty_score":0.9999027,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09254291781798765,"score_gpt":0.4808868178622886,"score_spread":0.388343900044301,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}